Assessment of the role of spleen tyrosine kinase and zeta-chain-associated 70-kDa protein (tyrosine) kinase in the pathogenesis of psoriasis
Sir, Spleen tyrosine kinase (Syk) and zeta-chain-associated 70 kDa protein kinase (ZAP-70) belong to the same family of tyrosine kinases (TKs). 1, 2 Syk was proposed to play a role in interleukin (IL)-17 signaling. 1 ZAP-70 is a key regulator of T-cell receptor (TCR) signalling, T-cell proliferation, differentiation and effector functioning. 2 Recent studies are highlighting an etiopathogenic role of these molecules in psoriasis. We studied both the tissue and serum expressions of the phosphorylated (active) forms of Syk and ZAP-70 in psoriasis.
We conducted a cross-sectional study involving 20 new patients with psoriasis (cases) and 20 age and sex matched healthy controls after obtaining approval from the Institutional Ethical Committee. Each patient was subjected to history taking and clinical examination to assess the extent of disease by documenting the Psoriasis Area and Severity Index (PASI) after obtaining their informed consent. The inclusion criteria included absence of any systemic treatment in the last 4 weeks while pregnancy, lactation, concomitant presence of other autoimmune diseases and erythrodermic or pustular psoriasis constituted the exclusion criteria.
We took a 4-mm punch biopsy from scaly psoriatic plaque and normal skin in cases and controls respectively. The control biopsies were taken from redundant skin of abdominoplasty, breast reduction and brachioplasty operations. Three millilitre of venous blood was withdrawn from each participant. The skin biopsies and serum samples were prepared for enzyme-linked immunosorbent assay (ELISA) examination to detect phosphorylated Syk and phosphorylated ZAP-70.
[Chongqing Biospes (Chongqing, China)].
The data was analysed to obtain clinio-demographic and biochemical profile of the subjects, which have been tabulated below [ Table 1 ]. Syk was downregulated in psoriatic skin and serum in comparison to the controls. However, only the serum reduction was statistically significant (P = 0.001). ZAP-70 levels also reduced significantly in both patients' skin (P = 0.007) and serum (P = 0.035) with reference to the the controls [ Figure 1 ]. There was no statistically significant association between tissue or serum levels of SyK and ZAP-70 with patients' sex, age, duration and extent of disease or PASI score. Wu et al. (2015) identified SyK as an upstream signaling molecule of IL-17R in human keratinocytes, suggesting it's pro-inflammatory role. 1 In contrast, Hamerman The other member of this family, ZAP-70, has not yet been studied in psoriasis. It was previously reported that single-nucleotide substitutions in the ZAP-70 gene and other molecules in this pathway have been associated with autoimmune diseases such as rheumatoid arthritis. 5 The downregulation of the phosphorylated ZAP-70 in our cases might hint towards it's mutation in psoriasis which may have resulted in it's reduced expression and function.
Studying the genetic expression of ZAP-70 in psoriasis might give us a real insight into its specific role in the disease's pathogenesis. This perplexing molecule might also provide a possible therapeutic target for psoriasis by modulating its activity.
The current work gives us insight on the possible role of Syk and ZAP-70 in psoriasis. The unexpected downregulation of Syk suggests a possible dual role and highlights the need for further research to establish its role as a therapeutic target in psoriasis. Moreover, the downregulation of ZAP-70 in our patients may have contributed to theimmune dysregulation. Our limitations include a small sample size and unavailability of polymerase chain reaction to assess protein levels due to financial constraints.
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